Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesCationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine
Clinical Microbiology and Infection, 06/02/09
Grare M et al. - The results raise the possibility that Cx1 may be a potent new antibacterial agent of somewhat lower activity but significantly lower toxicity than CHX.
R. E. Duval, 06/23/09
| At the moment, there are two major antiseptocs used in hospital: hexamidine and chlorhexidine, but very few data on their real efficiency on the multidrug resistant bacteria are available. One purpose of this work was to test these compounds against these bacteria and also to compare these two molecules with our leading compound, Cx1, which seems to be very interesting as well in term of antibacterial spectre as cytotoxic response. That is why Cx1 seems to us very promising. |
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Acquired activation of the Akt/COX-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis
Molecular Pharmacology, 12/04/09
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B
International Journal of Infectious Diseases, 12/04/09
Article Search
Sponsor